189 related articles for article (PubMed ID: 35836254)
1. Relationship between ATOH1 and tumor microenvironment in colon adenocarcinoma patients with different microsatellite instability status.
Mou W; Zhu L; Yang T; Lin A; Lyu Q; Guo L; Liu Z; Cheng Q; Zhang J; Luo P
Cancer Cell Int; 2022 Jul; 22(1):229. PubMed ID: 35836254
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Lin A; Zhang J; Luo P
Front Immunol; 2020; 11():2039. PubMed ID: 32903444
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
Front Immunol; 2021; 12():665002. PubMed ID: 34367132
[TBL] [Abstract][Full Text] [Related]
4. Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma.
Lin A; Xu W; Luo P; Zhang J
Front Pharmacol; 2021; 12():721181. PubMed ID: 34721019
[TBL] [Abstract][Full Text] [Related]
5. Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma.
Sun Z; Li G; Shang D; Zhang J; Ai L; Liu M
Front Immunol; 2022; 13():988303. PubMed ID: 36275690
[TBL] [Abstract][Full Text] [Related]
6. ASCL2 Affects the Efficacy of Immunotherapy in Colon Adenocarcinoma Based on Single-Cell RNA Sequencing Analysis.
Wu L; Sun S; Qu F; Liu X; Sun M; Pan Y; Zheng Y; Su G
Front Immunol; 2022; 13():829640. PubMed ID: 35774798
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment.
Lin A; Gu T; Hu X; Zhang J; Luo P
J Immunol Res; 2022; 2022():8179799. PubMed ID: 35707003
[TBL] [Abstract][Full Text] [Related]
8. Dissection of Immune Profiles in Microsatellite Stable and Low Microsatellite Instability Colon Adenocarcinoma by Multiomics Data Analysis.
Yang T; Lei J; Feng Q; Song D; Wang X
J Oncol; 2022; 2022():8588164. PubMed ID: 35466314
[TBL] [Abstract][Full Text] [Related]
9. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
10. Spatially aware graph neural networks and cross-level molecular profile prediction in colon cancer histopathology: a retrospective multi-cohort study.
Ding K; Zhou M; Wang H; Zhang S; Metaxas DN
Lancet Digit Health; 2022 Nov; 4(11):e787-e795. PubMed ID: 36307192
[TBL] [Abstract][Full Text] [Related]
11. Alteration in the Immune Microenvironment Based on APC Status in MSS/pMMR Colon Cancer.
Lin H; Cao B
Dis Markers; 2022; 2022():3592990. PubMed ID: 35937946
[TBL] [Abstract][Full Text] [Related]
12.
Sun Y; Li L; Yao W; Liu X; Yang Y; Ma B; Xue D
Front Genet; 2021; 12():762160. PubMed ID: 34795697
[TBL] [Abstract][Full Text] [Related]
13. Glutathione peroxidase 2: A key factor in the development of microsatellite instability in colon cancer.
Cui Z; Xu L; Wu H; Wang M; Lu L; Wu S
Pathol Res Pract; 2023 Mar; 243():154372. PubMed ID: 36796200
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
[TBL] [Abstract][Full Text] [Related]
16. The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses.
Zhou P; Wu X; Chen H; Hu Y; Zhang H; Wu L; Yang Y; Mao B; Wang H
Aging (Albany NY); 2020 Dec; 13(2):2365-2378. PubMed ID: 33318301
[TBL] [Abstract][Full Text] [Related]
17. High expression of PI4K2A predicted poor prognosis of colon adenocarcinoma (COAD) and correlated with immunity.
Huang X; Cao Y; Bao P; Zhu B; Cheng Z
Cancer Med; 2023 Jan; 12(1):837-851. PubMed ID: 35634680
[TBL] [Abstract][Full Text] [Related]
18. Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in colon adenocarcinoma.
Zheng L; Zhang J; Ye Y; Shi Z; Huang Y; Zhang M; Gui Z; Li P; Qin H; Sun W; Zhang M
Aging (Albany NY); 2023 Sep; 15(18):9521-9543. PubMed ID: 37724904
[TBL] [Abstract][Full Text] [Related]
19. Identification of the six-hormone secretion-related gene signature as a prognostic biomarker for colon adenocarcinoma.
Jia X; Zhang T; Lv X; Du H; Sun Y; Guan Y
Cancer Biomark; 2023; 38(4):523-535. PubMed ID: 38143338
[TBL] [Abstract][Full Text] [Related]
20. The role of a cuproptosis-related prognostic signature in colon cancer tumor microenvironment and immune responses.
Xu C; Liu Y; Zhang Y; Gao L
Front Genet; 2022; 13():928105. PubMed ID: 36313449
[No Abstract] [Full Text] [Related]
[Next] [New Search]
